These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 17148732

  • 1. Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome?
    Charmandari E, Chrousos GP.
    Ann N Y Acad Sci; 2006 Nov; 1083():37-53. PubMed ID: 17148732
    [Abstract] [Full Text] [Related]

  • 2. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - management in adults.
    Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E.
    Endokrynol Pol; 2010 Nov; 61(1):142-55. PubMed ID: 20205117
    [Abstract] [Full Text] [Related]

  • 3. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].
    Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E.
    Endokrynol Pol; 2010 Nov; 61 Suppl 1():7-21. PubMed ID: 22127631
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kim MS, Merke DP.
    Semin Reprod Med; 2009 Jul; 27(4):316-21. PubMed ID: 19530065
    [Abstract] [Full Text] [Related]

  • 5. NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Merke DP, Bornstein SR, Avila NA, Chrousos GP.
    Ann Intern Med; 2002 Feb 19; 136(4):320-34. PubMed ID: 11848730
    [Abstract] [Full Text] [Related]

  • 6. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications.
    Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP.
    J Clin Endocrinol Metab; 2002 May 19; 87(5):2114-20. PubMed ID: 11994350
    [Abstract] [Full Text] [Related]

  • 7. [Polycystic ovary syndrome of extra-ovarian origin. Review].
    Terán Dávila J, Teppa-Garrán AD.
    Invest Clin; 2001 Mar 19; 42(1):51-78. PubMed ID: 11294032
    [Abstract] [Full Text] [Related]

  • 8. Classic congenital adrenal hyperplasia and puberty.
    Charmandari E, Brook CG, Hindmarsh PC.
    Eur J Endocrinol; 2004 Nov 19; 151 Suppl 3():U77-82. PubMed ID: 15554890
    [Abstract] [Full Text] [Related]

  • 9. Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency.
    Ariyawatkul K, Tepmongkol S, Aroonparkmongkol S, Sahakitrungruang T.
    Eur J Pediatr; 2017 Apr 19; 176(4):537-545. PubMed ID: 28224294
    [Abstract] [Full Text] [Related]

  • 10. Metabolic disorders in newly diagnosed young adult female patients with simple virilizing 21-hydroxylase deficiency.
    Zhang HJ, Yang J, Zhang MN, Liu CQ, Xu M, Li XJ, Yang SY, Li XY.
    Endocrine; 2010 Oct 19; 38(2):260-5. PubMed ID: 20978868
    [Abstract] [Full Text] [Related]

  • 11. Polycystic ovarian disease and congenital and late-onset adrenal hyperplasia.
    New MI.
    Endocrinol Metab Clin North Am; 1988 Dec 19; 17(4):637-48. PubMed ID: 3058471
    [Abstract] [Full Text] [Related]

  • 12. Classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults.
    Bachelot A, Chakthoura Z, Rouxel A, Dulon J, Touraine P.
    Horm Res; 2008 Dec 19; 69(4):203-11. PubMed ID: 18204267
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia.
    Torky A, Sinaii N, Jha S, Desai J, El-Maouche D, Mallappa A, Merke DP.
    J Clin Endocrinol Metab; 2021 Nov 19; 106(12):e5247-e5257. PubMed ID: 33677504
    [Abstract] [Full Text] [Related]

  • 14. Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review.
    Papadakis G, Kandaraki EA, Tseniklidi E, Papalou O, Diamanti-Kandarakis E.
    Front Endocrinol (Lausanne); 2019 Nov 19; 10():388. PubMed ID: 31275245
    [Abstract] [Full Text] [Related]

  • 15. Normal ovarian structure and function with normal glucose tolerance in girls with early treatment of classic congenital adrenal hyperplasia.
    Fleischman A, Paltiel H, Chow J, Ringelheim J, Gordon CM.
    J Pediatr Adolesc Gynecol; 2007 Apr 19; 20(2):67-72. PubMed ID: 17418389
    [Abstract] [Full Text] [Related]

  • 16. Congenital adrenal hyperplasia.
    Merke DP, Bornstein SR.
    Lancet; 2007 Apr 19; 365(9477):2125-36. PubMed ID: 15964450
    [Abstract] [Full Text] [Related]

  • 17. 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender.
    Moran C, Azziz R.
    Semin Reprod Med; 2003 Aug 19; 21(3):295-300. PubMed ID: 14593552
    [Abstract] [Full Text] [Related]

  • 18. Components of Metabolic Syndrome in Youth With Classical Congenital Adrenal Hyperplasia.
    Kim MS, Fraga NR, Minaeian N, Geffner ME.
    Front Endocrinol (Lausanne); 2022 Aug 19; 13():848274. PubMed ID: 35399922
    [Abstract] [Full Text] [Related]

  • 19. Role of obesity and adiposity in polycystic ovary syndrome.
    Diamanti-Kandarakis E.
    Int J Obes (Lond); 2007 Nov 19; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
    [Abstract] [Full Text] [Related]

  • 20. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN, Merchant R.
    Semin Reprod Med; 2008 Jan 19; 26(1):22-34. PubMed ID: 18181079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.